CYB5R1 | Cytochrome b5 reductase 1 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
CYB5R2 | Cytochrome b5 reductase 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CYB5R3 | Cytochrome b5 reductase 3 | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CYB5RL | Cytochrome b5 reductase-like | Enzymes Predicted intracellular proteins
| | | | | Mixed |
CYP11A1 | Cytochrome P450, family 11, subfamily A, polypeptide 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
CYP11B1 | Cytochrome P450, family 11, subfamily B, polypeptide 1 | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enriched |
CYP11B2 | Cytochrome P450, family 11, subfamily B, polypeptide 2 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
CYP17A1 | Cytochrome P450, family 17, subfamily A, polypeptide 1 | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CYP19A1 | Cytochrome P450, family 19, subfamily A, polypeptide 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
CYP1A2 | Cytochrome P450, family 1, subfamily A, polypeptide 2 | Cancer-related genes Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
CYP1B1 | Cytochrome P450, family 1, subfamily B, polypeptide 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
CYP21A2 | Cytochrome P450, family 21, subfamily A, polypeptide 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
CYP24A1 | Cytochrome P450, family 24, subfamily A, polypeptide 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
CYP27A1 | Cytochrome P450, family 27, subfamily A, polypeptide 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
CYP2A13 | Cytochrome P450, family 2, subfamily A, polypeptide 13 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
CYP2A7 | Cytochrome P450, family 2, subfamily A, polypeptide 7 | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
CYP2C19 | Cytochrome P450, family 2, subfamily C, polypeptide 19 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP2C8 | Cytochrome P450, family 2, subfamily C, polypeptide 8 | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CYP2C9 | Cytochrome P450, family 2, subfamily C, polypeptide 9 | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
CYP2D6 | Cytochrome P450, family 2, subfamily D, polypeptide 6 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CYP2E1 | Cytochrome P450, family 2, subfamily E, polypeptide 1 | Cancer-related genes Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CYP3A4 | Cytochrome P450, family 3, subfamily A, polypeptide 4 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CYP3A43 | Cytochrome P450, family 3, subfamily A, polypeptide 43 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
CYP4B1 | Cytochrome P450, family 4, subfamily B, polypeptide 1 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CYP4F11 | Cytochrome P450, family 4, subfamily F, polypeptide 11 | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP4F2 | Cytochrome P450, family 4, subfamily F, polypeptide 2 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CYP51A1 | Cytochrome P450, family 51, subfamily A, polypeptide 1 | Enzymes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
DAO | D-amino-acid oxidase | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
DBH | Dopamine beta-hydroxylase (dopamine beta-monooxygenase) | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
DCXR | Dicarbonyl/L-xylulose reductase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
DDO | D-aspartate oxidase | Enzymes Predicted membrane proteins
| | | | | Mixed |
DECR1 | 2,4-dienoyl CoA reductase 1, mitochondrial | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
DHCR24 | 24-dehydrocholesterol reductase | Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
DHCR7 | 7-dehydrocholesterol reductase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
DHDH | Dihydrodiol dehydrogenase (dimeric) | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
DHODH | Dihydroorotate dehydrogenase (quinone) | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
DHRS3 | Dehydrogenase/reductase (SDR family) member 3 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
DHRS4 | Dehydrogenase/reductase (SDR family) member 4 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
DHTKD1 | Dehydrogenase E1 and transketolase domain containing 1 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
DIO2 | Deiodinase, iodothyronine, type II | Enzymes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
DLD | Dihydrolipoamide dehydrogenase | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
DMGDH | Dimethylglycine dehydrogenase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
EGLN2 | Egl-9 family hypoxia-inducible factor 2 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
EHHADH | Enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
ETFDH | Electron-transferring-flavoprotein dehydrogenase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ETHE1 | Ethylmalonic encephalopathy 1 | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
FAR1 | Fatty acyl CoA reductase 1 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
FASN | Fatty acid synthase | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
FDXR | Ferredoxin reductase | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
FMO3 | Flavin containing monooxygenase 3 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |